These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 30917489)
41. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951 [TBL] [Abstract][Full Text] [Related]
42. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis. Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285 [TBL] [Abstract][Full Text] [Related]
43. Administration of methyl palmitate prevents non-alcoholic steatohepatitis (NASH) by induction of PPAR-α. Zhang L; Li HX; Pan WS; Ullah Khan F; Qian C; Qi-Li FR; Xu X Biomed Pharmacother; 2019 Mar; 111():99-108. PubMed ID: 30579258 [TBL] [Abstract][Full Text] [Related]
44. MicroRNA 29a alleviates mitochondrial stress in diet-induced NAFLD by inhibiting the MAVS pathway. Yang YL; Chuang YT; Huang YH Eur J Pharmacol; 2024 Nov; 982():176955. PubMed ID: 39209098 [TBL] [Abstract][Full Text] [Related]
45. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534 [TBL] [Abstract][Full Text] [Related]
46. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257 [TBL] [Abstract][Full Text] [Related]
47. Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH. Tran M; Lee SM; Shin DJ; Wang L JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093267 [TBL] [Abstract][Full Text] [Related]
48. Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice. Yoshida T; Akiba J; Matsui T; Nakamura K; Hisamoto T; Abe M; Ikezono Y; Wada F; Iwamoto H; Nakamura T; Koga H; Yamagishi SI; Torimura T Dig Dis Sci; 2017 Jun; 62(6):1527-1536. PubMed ID: 28365916 [TBL] [Abstract][Full Text] [Related]
49. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316 [TBL] [Abstract][Full Text] [Related]
50. Protective effect of isochlorogenic acid B on liver fibrosis in non-alcoholic steatohepatitis of mice. Liu X; Huang K; Niu Z; Mei D; Zhang B Basic Clin Pharmacol Toxicol; 2019 Feb; 124(2):144-153. PubMed ID: 30180301 [TBL] [Abstract][Full Text] [Related]
52. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance. Meroni M; Longo M; Erconi V; Valenti L; Gatti S; Fracanzani AL; Dongiovanni P Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671785 [TBL] [Abstract][Full Text] [Related]
53. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats. Saleh DO; Ahmed RF; Amin MM Appl Physiol Nutr Metab; 2017 Mar; 42(3):243-249. PubMed ID: 28177750 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. Huang YH; Kuo HC; Yang YL; Wang FS Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801 [TBL] [Abstract][Full Text] [Related]
55. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis. González-Rodríguez Á; Valdecantos MP; Rada P; Addante A; Barahona I; Rey E; Pardo V; Ruiz L; Laiglesia LM; Moreno-Aliaga MJ; García-Monzón C; Sánchez A; Valverde ÁM Mol Metab; 2018 Jan; 7():132-146. PubMed ID: 29126873 [TBL] [Abstract][Full Text] [Related]
56. A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL/6J mouse. Gautam J; Aggarwal H; Kumari D; Gupta SK; Kumar Y; Dikshit M Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Dec; 1869(8):159545. PubMed ID: 39089643 [TBL] [Abstract][Full Text] [Related]
57. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice. Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis. Katsura A; Morishita A; Iwama H; Tani J; Sakamoto T; Tatsuta M; Toyota Y; Fujita K; Kato K; Maeda E; Nomura T; Miyoshi H; Yoneyama H; Himoto T; Fujiwara S; Kobara H; Mori H; Niki T; Ono M; Hirashima M; Masaki T Int J Mol Med; 2015 Apr; 35(4):877-84. PubMed ID: 25672270 [TBL] [Abstract][Full Text] [Related]
59. Indole supplementation ameliorates MCD-induced NASH in mice. Zhu B; Li H; Lu B; Guo X; Wu C; Wang F; Li Q; Xie L; Glaser S; Francis H; Alpini G; Wu C J Nutr Biochem; 2022 Sep; 107():109041. PubMed ID: 35568098 [TBL] [Abstract][Full Text] [Related]